EMQ ANSWERS
For questions on page
792
| The first 150 words of the full text of this article appear below. |
ANSWER 1
- False. There is no evidence that a rhythm control strategy is generally superior to a rate control strategy.1 2 The National Institute for Health and Clinical Excellence recommends consideration of rhythm control in the following patient groups: the symptomatic; those aged <65 years; those with a first presentation of lone atrial fibrillation (AF; see definition in 1d); those with AF secondary to a treated precipitant; those with congestive cardiac failure.
- False. Most AF-related mortality is due to thromboembolic complications especially stroke.3 AF accounts for up to 25% of all strokes in the elderly.4
- False. All AF patients should be assessed for their risk of stroke. Only those with moderate to high risk are likely to benefit from anticoagulation.5 For example, patients under 65 years with no comorbidities would not normally benefit from anticoagulation.
- False. Lone AF means that no precipitant has been found (eg, ischaemic heart disease). Pill-in-the-pocket therapy is appropriate
. . . [Full text of this article]
Relevant Article
-
See page 860 for answers
Emerg. Med. J. 2008 25: 792.[Extract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
